Aethlon Medical submits IDE for safety study of Hemopurifier
By KAREN YOUNG
Medical Device Daily Staff Writer
In the latest chapter in its ongoing drive toward commercialization of its Hemopurifier, Aethlon Medical (San Diego) said it has submitted an investigational device exemption to the FDA requesting permission to initiate human safety studies as well as a treatment counter-measure against select category "A" bioterror threats.
Those bioterror threats now include Ebola hemorrhagic virus and Marburg hemorrhagic virus, Aethlon's CEO/chairman James Joyce told Medical Device Daily.
Medical Device Week
March 8, 2007
In other braking news it has been reported that Aethlon is working on a molasses purification system, but the CEO warned that it will be slow going.